CM082 , a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant nonâsmall cell lung cancer in vitro and in vivo
Zhang, Kun, Wang, Lili, Wei, Aili, Jia, Xinfei, Liu, XiaoqingJournal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13430
Date:
May, 2020
File:
PDF, 4.14 MB
2020